Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zorini, A. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zorini, A. O.
(Chest. 1963;43:131-141.)
© 1963 American College of Chest Physicians

Further Developments in Human and Bovine Antituberculosis Chemoprophylaxis with Isoniazid in Italy

Attilio Omodei Zorini M.D., F.C.C.P.1

1 Carlo Forlanini Study Center and the Tuberculosis Clinic, University of Rome

1. Calves submitted to chemoprophylaxis after primary infection resulting from exposure to tuberculous cows acquired an immunity which protected them against a massive parenteral reinfection with bovine tubercle bacilli. This immunity corresponds to that obtained by BCG vaccination and is present even if the reinfection occurs six months after discontinuance of chemoprophylaxis.

2. Large-scale trials with chemoprophylaxis on human beings have been carried out in Italy since April, 1956. Chemoprophylaxis has been used in selected groups exposed to tuberculosis in households and schools. These groups include all tuberculin-positive children under five years and adolescents in families with a tuberculous background, especially when living with tuberculous individuals.

3. The procedure might be expected to be beneficial in adults who had had tuberculosis, in tuberculous subjects in order to avoid relapses, as well as in silicotic and siderotic miners.

4. Chemoprophylaxis should be integrated with antituberculosis vaccination and nonspecific prophylaxis which still are the bases of the prevention of tuberculosis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1963 by the American College of Chest Physicians.